Experiences of decision making about psychotropic medication during pregnancy and breastfeeding in women living with severe mental illness: a qualitative study.
Jacqueline FrayneR ElliesT NguyenPublished in: Archives of women's mental health (2023)
Findings offer understanding of patients' experiences in the decision-making and use of psychotropic medication during pregnancy and breastfeeding. Women living with severe mental illnesses, such as bipolar and psychosis, face difficult medication decisions due to uncertainty around use in pregnancy, potentially causing conflict with their dual role as both persons with a diagnosed mental illness but also new mothers. The clinician needs to provide comprehensible and concise information, giving space for a woman's voice to be heard to guide them from a position of hesitancy to one of assurance. Collaboration within a multidisciplinary team and external care providers combined with consistency of care assists this process.
Keyphrases
- mental illness
- mental health
- decision making
- healthcare
- palliative care
- quality improvement
- pregnancy outcomes
- polycystic ovary syndrome
- end stage renal disease
- adverse drug
- newly diagnosed
- preterm infants
- ejection fraction
- early onset
- chronic kidney disease
- bipolar disorder
- prognostic factors
- pain management
- preterm birth
- cervical cancer screening
- breast cancer risk
- peritoneal dialysis
- affordable care act
- metabolic syndrome
- chronic pain
- health insurance
- insulin resistance
- adipose tissue
- quality control